Monday, September 27, 2021

Singapore to give vaccine boosters as cases rise

The health ministry says an expert committee has recommended a third dose for people aged 60 and above and those with weak immune systems.

Other News

Singapore will start giving coronavirus vaccine booster shots to the elderly and those with weak immune systems, officials said Friday, as cases rise despite high inoculation rates.

The city-state joins a number of countries worldwide in giving a third jab to the most vulnerable groups, as it faces a new outbreak driven by the Delta variant.

The health ministry said an expert committee had recommended the third dose for people aged 60 and above and those with weak immune systems.

Health Minister Ong Ye Kung described the decision as a “preemptive step before antibodies wane further”.

For the over 60s, the boosters can be given six to nine months after the second shot, which means as early as this month for some, Ong said.

For those with weak immune systems, it should be administered after two months. Immune systems can be weakened by some diseases, or by treatments for illnesses such as cancer.

Giving a third jab to the most vulnerable groups is in line with measures adopted in other countries, such as Israel and Germany, according to the health ministry.

The US Food and Drug Administration has also approved a third dose for those with weak immune systems, and is considering it for the elderly.

Singapore has shifted to a strategy of living with the virus instead of regularly imposing lockdowns to eradicate it as vaccination rates increase.

More than 80% of the population are fully inoculated but officials say easing domestic restrictions and opening borders will only be done gradually.

Singapore has seen a steady uptick in infections in recent weeks, and is now reporting more than 100 cases a day and regular deaths.

But its outbreak has generally been mild, with about 68,000 infections and 55 deaths.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles